Sign in

CIK 0001682852

  • Large accelerated filer

Moderna, Inc.

Sign in to watch
Ticker
MRNA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
813467528
Phone
+1 617-714-6500
Business address
325 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
Moderna Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$50,775,837
in 5 filings, $50.8M under 10b5-1 plans

Net −$50,775,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-11-29 Hoge Stephen President Sale 10b5-1 −1,136 $79.81 $91K 1,575,721
2023-11-28 Hoge Stephen President Exercise or conversion 10b5-1 +2,411 1,576,857
2023-11-28 Hoge Stephen President Exercise or conversion · Restricted Stock Units 10b5-1 −2,411 2,411
2023-11-10 Hoge Stephen President Sale 10b5-1 −263 $68.76 $18K 1,574,446
2023-11-09 Hoge Stephen President Exercise or conversion 10b5-1 +522 1,574,709
2023-11-09 Hoge Stephen President Exercise or conversion · Restricted Stock Units 10b5-1 −522 2,612
2023-11-01 AFEYAN NOUBAR Director Sale 10b5-1 −1,900 $75.30 $143K 2,155,031
2023-11-01 AFEYAN NOUBAR Director Sale 10b5-1 −8,100 $76.17 $617K 2,146,931
2023-10-25 AFEYAN NOUBAR Director Sale 10b5-1 −6,500 $76.73 $499K 2,160,431
2023-10-25 AFEYAN NOUBAR Director Sale 10b5-1 −3,100 $77.34 $240K 2,157,331
2023-10-25 AFEYAN NOUBAR Director Sale 10b5-1 −400 $78.42 $31K 2,156,931
2023-10-11 AFEYAN NOUBAR Director Sale 10b5-1 −8,700 $102.88 $895K 2,173,231
2023-10-11 AFEYAN NOUBAR Director Sale 10b5-1 −5,700 $103.76 $591K 2,167,531
2023-10-11 AFEYAN NOUBAR Director Sale 10b5-1 −500 $104.82 $52K 2,167,031
2023-10-11 AFEYAN NOUBAR Director Sale 10b5-1 −100 $105.58 $11K 2,166,931
2023-10-06 Mock James M Chief Financial Officer Sale 10b5-1 −2,858 $102.50 $293K 2,952
2023-10-05 Mock James M Chief Financial Officer Exercise or conversion 10b5-1 +5,810 5,810
2023-10-05 Mock James M Chief Financial Officer Exercise or conversion · Restricted Stock Units 10b5-1 −5,810 17,432
2023-10-04 AFEYAN NOUBAR Director Sale 10b5-1 −1,030 $100.02 $103K 2,195,901
2023-10-04 AFEYAN NOUBAR Director Sale 10b5-1 −1,800 $100.94 $182K 2,194,101

Page 37 of 38 · 743 trades